Sudeep Pharma (SUDEEPPHRM)
FAST GROWERFairStock Score: 48/100 — MIXED
Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹687.95 |
| Market Cap | ₹7,216.85 Cr |
| P/E Ratio | 45.82 |
| ROCE | 35.65% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 65.31% |
| Debt/Equity | 0.19 |
| Sales Growth | 49.16% |
| Promoter Holding | 76.15% |
| 52-Week Range | ₹524.05 — ₹815.85 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹66.5 |
Sudeep Pharma trades with a P/E ratio of 45.82, ROCE of 35.65%, profit growth of 65.31%, debt-to-equity of 0.19. The FairStock Score of 48/100 suggests mixed fundamentals — some metrics look solid while others need improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer